Lynch Michael
Department of Biology, Indiana University, Bloomington, Indiana 47401
Genetics. 2016 Mar;202(3):869-75. doi: 10.1534/genetics.115.180471.
Although the human germline mutation rate is higher than that in any other well-studied species, the rate is not exceptional once the effective genome size and effective population size are taken into consideration. Human somatic mutation rates are substantially elevated above those in the germline, but this is also seen in other species. What is exceptional about humans is the recent detachment from the challenges of the natural environment and the ability to modify phenotypic traits in ways that mitigate the fitness effects of mutations, e.g., precision and personalized medicine. This results in a relaxation of selection against mildly deleterious mutations, including those magnifying the mutation rate itself. The long-term consequence of such effects is an expected genetic deterioration in the baseline human condition, potentially measurable on the timescale of a few generations in westernized societies, and because the brain is a particularly large mutational target, this is of particular concern. Ultimately, the price will have to be covered by further investment in various forms of medical intervention. Resolving the uncertainties of the magnitude and timescale of these effects will require the establishment of stable, standardized, multigenerational measurement procedures for various human traits.
尽管人类种系突变率高于其他任何经过充分研究的物种,但一旦考虑到有效基因组大小和有效种群大小,这一比率就并不异常。人类体细胞突变率大幅高于种系突变率,但这在其他物种中也有体现。人类与众不同之处在于最近摆脱了自然环境的挑战,并且有能力以减轻突变对适应性影响的方式改变表型特征,例如精准医学和个性化医疗。这导致对轻度有害突变的选择压力放松,包括那些会放大突变率本身的突变。这种影响的长期后果是预计人类基线状况会出现基因退化,在西方化社会中可能在几代人的时间尺度上就可测量,而且由于大脑是一个特别大的突变靶点,这尤其令人担忧。最终,必须通过对各种形式的医疗干预进行进一步投资来弥补代价。解决这些影响的程度和时间尺度的不确定性将需要为各种人类特征建立稳定、标准化的多代测量程序。